Clinical Trials, page-302

All pie in the sky stuff but realistically I wonder in reality how fast we could go through a phase 1 and 2 trial and if successful be ready for phase 3.

Given you wouldn't necessarily need a big cohort, and with the pace the virus moves through it's phases, and perhaps the speed with which our drug goes to work....i imagine the most time consuming part will be the paperwork, trial design, peer review, bureaucracy etc.

So a longer wait at the front end, with a more rapid progression through actual testing. Fingers crossed it works. I'd be more than happy with a $3b valuation let alone a $6b valuation but I'll take it!